Difficulty: Medium
Average Score: 88%
Practice
A 21-year-old man presents to his primary care physician with 6 weeks of painful, bloody stools. Flexible sigmoidoscopy reveals erythema and friability with pseudopolyps. Which drug used for ulcerative colitis is made of two identical smaller molecules linked together with an azo bond?
Correct answer
D
Rationale
The correct answer is D) Olsalazine. Olsalazine is a drug used for ulcerative colitis that is made of two identical smaller molecules linked together with an azo bond. This unique chemical structure allows for localized action in the colon, where it is broken down into its active form, mesalamine, providing anti-inflammatory effects specifically at the site of inflammation in ulcerative colitis.
Option A) Azathioprine is a purine analog that acts as an immunosuppressant and is not structurally related to the azo-bonded drugs used for ulcerative colitis.
Option B) Cyclosporine is an immunosuppressant drug used in various autoimmune conditions but is not indicated for ulcerative colitis and does not have the azo bond structure.
Option C) Sulfasalazine is another drug used for ulcerative colitis, but it consists of a combination of sulfapyridine and 5-aminosalicylic acid, not two identical smaller molecules linked by an azo bond like olsalazine.
Understanding the chemical structure and mechanism of action of medications used for ulcerative colitis is crucial in selecting the most appropriate treatment for patients. Olsalazine's unique formulation allows for targeted therapy with minimized systemic side effects, making it a valuable option in the management of inflammatory bowel disease.
Option A) Azathioprine is a purine analog that acts as an immunosuppressant and is not structurally related to the azo-bonded drugs used for ulcerative colitis.
Option B) Cyclosporine is an immunosuppressant drug used in various autoimmune conditions but is not indicated for ulcerative colitis and does not have the azo bond structure.
Option C) Sulfasalazine is another drug used for ulcerative colitis, but it consists of a combination of sulfapyridine and 5-aminosalicylic acid, not two identical smaller molecules linked by an azo bond like olsalazine.
Understanding the chemical structure and mechanism of action of medications used for ulcerative colitis is crucial in selecting the most appropriate treatment for patients. Olsalazine's unique formulation allows for targeted therapy with minimized systemic side effects, making it a valuable option in the management of inflammatory bowel disease.